Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Streifeneder is a German orthopaedics, prosthetics, rehabilitation, and medical supply group serving both patients and professional O&P customers. The group includes F. G. Streifeneder KG, which operates medical supply stores and orthopaedic and hospital workshops, and Streifeneder ortho.production GmbH, which develops, manufactures, and distributes prosthetics, orthotics, wound care shoes, materials, and workshop equipment. Its business is focused on commercialized mobility and rehabilitation products and related care services rather than drug development. In 2025, Embla Medical completed the acquisition of a 51% majority stake in Streifeneder ortho.production GmbH, while the broader Streifeneder group continues to operate in Germany. The company appears best categorized as a healthcare and medical device organization with strong positioning in orthopaedic mobility solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Streifeneder.